My Blog

Post title:
Post content:	Жаль, что сейчас не могу высказаться - опаздываю на встречу. Вернусь - обязательно выскажу своё мнение. “The exception for {one\|one girl\|one girl} and {the same\|boring} surgical procedure (ssp)” in 21 cfr 1271.15(b) states that {which\|what} is not {necessary\|required} {observe\|follow\|observe} the {principles\|rules\|requirements} set forth in {some\|part} 1271 21 cfr, {if\|if} {institution\|organization\|institution} {aggregates\|collects\|selects} and injects hct/p autologously, in the {mode\|framework} of {the same surgical {work\|procedure\|actions} and {during\|during} {volume\|their} original form ({if\|if} {they\|are} processed, {allowed\|out} {only\|only} washing, cleaning, calibration and shaping) (227, 228). in {otherwise\|other situation\|other case}, the algorithm {gets\|departs\|proceeds to} the requirements of 21 cfr 1271.10(a). The criteria given {in this section\|here\|here} indicate {the\|fact\|nuance} that hct/p is subjected to minimal manipulation; {intended for\|focused on} homologous {work\|application\| use} is not combined with {surrounding\|other} {active substances\|active substances}; does not {have \| has} a systemic {effectiveness \|action \| effect} and {in case \| when} a systemic effect occurs, it is administered autologously or to blood relatives of the first /second degree of kinship (227). if {these\|such\|similar\|data} criteria are met, the FDA {implies\|authorizes} the use of cellular {treatment\|therapy} within the {rates\|limits} of regulatory guidelines governing the transmission of {diseases\|pathologies}, {but\|however} without prior approval {on the market\|in the field of trade}/submitting {an application\|application} for {licensing\|obtaining a license} for biologics, exclusively {in accordance with\|under\|respectively\|in accordance with} section 361 of the Public Health Service Act (PHS) and {requirements\|provisions} 21 CFR, Part 1271. {otherwise\|otherwise\|in a different way\|in a different way}, if a cell therapy {contradicts\|does not meet} the criteria {set forth\|set forth in\|listed in} 21 cfr 1271.10(a), it is regulated as a biological product {according to\|in accordance with\|according to} The Federal Law on {Products\|Foodstuffs\|Foodstuffs}, Medicines, #file_links["C:\Users\Admin\Desktop\file\gsa+en+50kGeorgiy2504253URLBB.txt",1,N] and Cosmetology (fd{timely\|effective} {treatment\|cure} of spontaneous metastases resulting from {eventually\|eventually\|as a result of} mildly immunogenic mouse breast carcinoma by combined vaccination with a hybrid dendritic tumor and adoptive transfer of T cells {sensitive\|susceptible\|unstable} to #file_links["C:\Users\Admin\Desktop\file\gsa+en+50kGeorgiy2504253URLBB.txt",1,N].

Post title:

Post content:

Жаль, что сейчас не могу высказаться - опаздываю на встречу. Вернусь - обязательно выскажу своё мнение.
 “The exception for {one|one girl|one girl} and {the same|boring} surgical procedure (ssp)” in 21 cfr 1271.15(b) states that {which|what} is not {necessary|required} {observe|follow|observe} the {principles|rules|requirements} set forth in {some|part} 1271 21 cfr, {if|if} {institution|organization|institution} {aggregates|collects|selects} and injects hct/p autologously, in the {mode|framework} of {the same surgical {work|procedure|actions} and {during|during} {volume|their} original form ({if|if} {they|are} processed, {allowed|out} {only|only} washing, cleaning, calibration and shaping) (227, 228). in {otherwise|other situation|other case}, the algorithm {gets|departs|proceeds to} the requirements of 21 cfr 1271.10(a). The criteria given {in this section|here|here} indicate {the|fact|nuance} that hct/p is subjected to minimal manipulation; {intended for|focused on} homologous {work|application| use} is not combined with {surrounding|other} {active substances|active substances}; does not {have | has} a systemic {effectiveness |action | effect} and {in case | when} a systemic effect occurs, it is administered autologously or to blood relatives of the first /second degree of kinship (227). if {these|such|similar|data} criteria are met, the FDA {implies|authorizes} the use of cellular {treatment|therapy} within the {rates|limits} of regulatory guidelines governing the transmission of {diseases|pathologies}, {but|however} without prior approval {on the market|in the field of trade}/submitting {an application|application} for {licensing|obtaining a license} for biologics, exclusively {in accordance with|under|respectively|in accordance with} section 361 of the Public Health Service Act (PHS) and {requirements|provisions} 21 CFR, Part 1271. {otherwise|otherwise|in a different way|in a different way}, if a cell therapy {contradicts|does not meet} the criteria {set forth|set forth in|listed in} 21 cfr 1271.10(a), it is regulated as a biological product {according to|in accordance with|according to} The Federal Law on {Products|Foodstuffs|Foodstuffs}, Medicines, #file_links["C:\Users\Admin\Desktop\file\gsa+en+50kGeorgiy2504253URLBB.txt",1,N] and Cosmetology (fd{timely|effective} {treatment|cure} of spontaneous metastases resulting from {eventually|eventually|as a result of} mildly immunogenic mouse breast carcinoma by combined vaccination with a hybrid dendritic tumor and adoptive transfer of T cells {sensitive|susceptible|unstable} to #file_links["C:\Users\Admin\Desktop\file\gsa+en+50kGeorgiy2504253URLBB.txt",1,N].

Edit stem cell therapy p375p

Delete post